Aytu BioScience (NASDAQ: AYTU) — Perfil da empresa, notícias e dados financeiros
Aytu BioScience develops novel healthcare products, addressing unmet needs in pediatrics and reproductive health.
Aytu BioScience
Aytu BioScience (NASDAQ:AYTU) is a dynamic healthcare company engaged in developing and commercializing novel products in the fields of pediatrics and reproductive health. Among its innovative offerings are treatments for conditions ranging from sleep disorders to testosterone replacement therapy. The company's mission revolves around addressing unmet or underserved medical needs, aiming to improve patient care with its diversified portfolio. Aytu BioScience is committed to expanding its presence in the healthcare industry through strategic acquisitions, research and development, and collaborations that enhance its product range and market reach.
Resumo
Operações
Produtos e/ou serviços de Aytu BioScience
- A treatment for nocturnal polyuria, a condition causing excessive urination during the night.
- Consumer health products, including dietary supplements and wellness products.
- A portfolio of prescription products aimed at addressing conditions in primary care settings.
- A therapeutic for male hypogonadism, a condition characterized by low testosterone levels.
- A product line dedicated to pediatric healthcare, including treatments for certain rare diseases.
- Diagnostic and testing solutions for various medical conditions, including COVID-19 rapid tests.
equipe executiva do Aytu BioScience
- Joshua R. DisbrowCEO & Director
- Ryan J. SelhornCFO, Corporate Secretary & Treasurer
- Jarrett T. DisbrowChief Business Officer
- Greg PyszczymukaChief Commercial Officer
- Margaret CabanoVice President of Operations
- Gerwin WestfieldSenior Vice President of Scientific Affairs
Principais indicadores financeiros
Resultados divulgados pela Aytu BioScience, em USD.
- Cap. de mercado
- 21,4 mi
- Receita (TTM)
- 57,6 mi
- P/L
- —
- LPA (diluído, TTM)
- -1.2
- Dividend yield
- —
- Margem de lucro
- -24.8%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 57,6 mi | -8,3 mi | -14,3 mi | |
| 66,4 mi | -7,8 mi | -13,6 mi | |
| 65,2 mi | -1,6 mi | -15,8 mi | |
| 107,4 mi | -17,1 mi | -17,1 mi |